We recently compiled a list of 7 cheap new stocks to invest in now. In this article, we'll take a look at how GE Healthcare Technologies (NASDAQ:GEHC) stands compared to other cheap new stocks.Capital markets are in turmoil due to Fed interest rate cutsRecent Fed decisions have sparked optimism about increased capital market activity. Analysts have expressed increasing confidence that the economy will have a soft landing despite continued market volatility. This perspective suggests that supportive monetary policy can boost valuations and create favorable conditions for investment, creating opportunities for companies to pursue IPOs and M&A. Investor interest in high-tech…
Author: admin
The UK's National Health Service (NHS) is implementing strategies to cope with the additional pressures expected during the winter season, with a focus on providing urgent care directly to elderly and frail patients in their own homes. The initiative aims to prevent overcrowding in hospitals and ensure timely treatment for patients in need. Local community-based rapid response teams are tasked with responding to non-clinically urgent calls within two hours. These teams are equipped to treat a wide range of conditions in patients' homes, thereby avoiding hospital stays and admissions. These operate 24 hours a day across England and represent a…
Revenue: USD 8.84 million (up 127% from Q3 2023). Net income: USD 1.22 million (up from a loss of USD 1.45 million in Q3 2023). Margin: 14% (up from net loss in Q3 2023). The transition to profitability was driven by revenue growth. EPS: USD 0.074 (up from loss of USD 0.089 in Q3 2023). NasdaqCM:SRTS Earnings and Revenue Growth November 17, 2024 All numbers shown in the chart above are for the trailing 12 month (TTM) period. Sales exceeded analysts' expectations by 50%. Earnings per share (EPS) also exceeded analyst expectations. Looking ahead, revenues are expected to increase by…
We recently published a list of the 8 most promising healthcare stocks by hedge funds. In this article, we'll take a look at how AbbVie Inc. (NYSE:ABBV) stands compared to the other most promising healthcare stocks, according to hedge funds. The healthcare sector relies on advances in medical technology, particularly devices used to prevent, diagnose, and treat diseases. Unlike pharmaceuticals, medical devices work through physical or mechanical means rather than chemical processes. Major products include pacemakers, imaging devices, dialysis machines, and implants. The healthcare sector is growing in the United States. According to recent estimates, the country's health spending will…
Revenue: RM12.3 million (up 7.0% from Q3 2023). Net profit: RM1.5 million (stable with Q3 2023). Profit margin: 12% (same as Q3 2023). EPS: RM0.002 (consistent with Q3 2023). KLSE:METRO Earnings and Revenue History as of November 24, 2024 All numbers shown in the chart above are for the trailing 12 month (TTM) period. Looking ahead, revenues are expected to grow by an average of 12% over the next three years, compared to a growth forecast of 6.2% for the Malaysian healthcare industry. Malaysian healthcare industry performance. The company's stock price has fallen 12% from a week ago. What about…
We recently published a list of the 8 most promising healthcare stocks by hedge funds. In this article, we'll take a look at how Johnson & Johnson (NYSE:JNJ) stands compared to the other most promising healthcare stocks, according to hedge funds. The healthcare sector relies on advances in medical technology, particularly devices used to prevent, diagnose, and treat diseases. Unlike pharmaceuticals, medical devices work through physical or mechanical means rather than chemical processes. Major products include pacemakers, imaging devices, dialysis machines, and implants. The healthcare sector is growing in the United States. According to recent estimates, the country's health spending…
We recently published a list of the 8 most promising healthcare stocks by hedge funds. In this article, we'll take a look at how Eli Lilly & Company (NYSE:LLY) stands compared to the other most promising healthcare stocks, according to hedge funds. The healthcare sector relies on advances in medical technology, particularly devices used to prevent, diagnose, and treat diseases. Unlike pharmaceuticals, medical devices work through physical or mechanical means rather than chemical processes. Major products include pacemakers, imaging devices, dialysis machines, and implants. The healthcare sector is growing in the United States. According to recent estimates, the country's health…
We recently compiled a list of 10 oversold healthcare stocks to invest in. In this article, we'll take a look at how Moderna, Inc. (NASDAQ:MRNA) stands compared to other oversold healthcare stocks. Investing in healthcare stocks during economic downturns is generally considered defensive. This is because people typically do not reduce their use of prescription drugs and other important health services even during economically difficult times. National health spending is projected to reach an estimated $4.8 trillion in 2023 and grow at an annual rate of 5.6% from 2027 to 2032, according to the Centers for Medicare and Medicaid Services…
We recently compiled a list of the 10 worst-performing healthcare stocks of 2024. In this article, we'll take a look at how Moderna, Inc. (NASDAQ:MRNA) stands compared to other healthcare stocks. The healthcare industry continues to be an important and resilient sector driven by technological advances, increasing global demand, and an aging population. ReportLinker predicts that the healthcare services industry will grow from $7.5 trillion in 2022 to $7.975 trillion in 2023. It is expected to grow at a compound annual growth rate (CAGR) of 6.3%, or $9.8 trillion, through 2027. The global healthcare market is divided into several segments…
We recently compiled a list of the 10 worst-performing healthcare stocks of 2024. In this article, we'll take a look at how Biogen, Inc. (NASDAQ:BIIB) stands compared to other healthcare stocks. The healthcare industry continues to be an important and resilient sector driven by technological advances, increasing global demand, and an aging population. ReportLinker predicts that the healthcare services industry will grow from $7.5 trillion in 2022 to $7.975 trillion in 2023. It is expected to grow at a compound annual growth rate (CAGR) of 6.3%, or $9.8 trillion, through 2027. The global healthcare market is divided into several segments…